Navigation Links
New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition
Date:3/14/2010

unction. Left ventricular diastolic volumes decreased a significant 13 percent (p<0.0001) and left ventricular diastolic dimensions decreased a significant 6.4 percent (p<0.0001) compared to baseline.
  • An improvement in symptoms, with 97.5 percent of patients exhibiting no symptoms (NYHA Functional Class I) or mild symptoms (NYHA Functional Class II) [p<0.0001], whereas at baseline, 52.6 percent of patients had moderate symptoms (NYHA Functional Class III) or severe symptoms (NYHA Functional Class IV). Patients who are classified as NYHA Functional Class III or IV experience marked or severe limitations in physical activity.
  • Meaningful improvements in both physical and mental quality of life compared to baseline as measured by the SF-36 Survey (increase of 4.7 points in the physical quality of life score [p<0.0001] and increase of 5.8 points in the mental quality of life score [p<0.0001]).

  • "The EVEREST II safety and effectiveness results support the MitraClip device as a treatment choice, and show that MitraClip patients still have the option for successful mitral valve surgery afterward if needed," said Donald Glower, M.D., professor of surgery, Cardiovascular and Thoracic Surgery Division, Duke University School of Medicine, Durham, NC; and co-principal investigator of the EVEREST II trial. "The improvements in symptoms, quality of life and cardiac function shown in the EVEREST II trial suggest the MitraClip procedure may be another valuable treatment option for certain patients with significant MR."


    '/>"/>
    SOURCE Abbott
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. New Study Demonstrates Safety of Balloon Sinuplasty(TM) Technology in Pediatric Patients Suffering From Chronic Sinusitis
    2. Tobiras Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
    3. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
    4. AsepticSure(TM) Hospital Sterilization System Demonstrates Total Eradication of Super Bugs
    5. Phase 2 Trial of LX4211 Demonstrates Significant and Rapid Improvements in Multiple Parameters in Type 2 Diabetic Patients
    6. Study Demonstrates Value of HPV Screening to Prevent Invasive Cervical Cancer
    7. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
    8. ANA598 Demonstrates Positive 4-Week Results at 200 mg BID
    9. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
    10. Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection
    11. European Lung Cancer Screening Trial Demonstrates New Inexpensive Strategy for Improving Accuracy of Diagnosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... NEW YORK and KISSING, Germany ... manufacturer and distributor of a single use and computer-assisted ... Nachum (Homi) Shamir , a worldwide recognized medical device ... Mr. Shamir is a highly respected ... most recent assignment he served as President and Chief ...
    (Date:7/30/2014)... PARIS , July 30, 2014  Regeneron Pharmaceuticals, ... SAN and NYSE: SNY ) today announced ... in people with hypercholesterolemia met their primary efficacy endpoint ... lipoprotein cholesterol (LDL-C) at 24 weeks compared to placebo ... targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
    (Date:7/30/2014)... July 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: ... into the cannabis testing and education markets, announced today ... and affairs not previously disclosed or, to its knowledge, ... market action. "We have noticed unusual price ... three trading days," said Steve Barbee , CEO ...
    Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2
    ... , SAN FRANCISCO, Nov. 4 VIA Pharmaceuticals, Inc. ... the development of compounds for the treatment of cardiovascular ... Senior Vice President Research & Development will present "VIA-3196, ... in the Abstract Oral Session on Novel Biological Mechanisms ...
    ... CVS Caremark (NYSE: CVS ) today announced ... SVP, Marketing for its pharmacy benefit management business. ... Jack Bruner, who is transitioning to the new role ... http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO ) , Greer brings twenty years ...
    Cached Medicine Technology:VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 2VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 3VIA Pharmaceuticals Featured at American Heart Association Scientific Sessions 2009 4Company Appoints New SVP, Marketing for PBM Business 2
    (Date:7/30/2014)... Victory Medical Center Craig Ranch , ... launch of a pediatric unit focused on: orthopedics, ear, ... working in the pediatrics departments are all specially trained ... Dr. Timothy Cole, Dr. Dale Ehmer, Dr. Barry Humeniuk, ... and Dr. Nicholas Peiffer lead the pediatrics team. Victory ...
    (Date:7/30/2014)... Building ENT and Allergy Associates (ENTA) into the ... Westchester County takes the best of everything. Leading physicians, ... structure and protocols, and a staff that is second ... Financial Officer to help run it. According to the ... possesses. In fact, in the WCBJ’s July 21st, 2014 ...
    (Date:7/30/2014)... TUESDAY, July 29, 2014 (HealthDay News) -- A simple ... as spina bifida, new research finds. The test ... B) in a pregnant women,s red blood cells. The findings ... scientists -- could help doctors predict the risk of serious ... vital to the proper development of a growing fetus. ...
    (Date:7/30/2014)... Tallahassee, FL (PRWEB) July 30, 2014 ... engineering doctoral candidate Renee Gordon and biochemistry professor ... August to conduct research as Fulbright Scholars. The ... international education exchange program that awards grants to ... teach and conduct research abroad. Both Gordon and ...
    (Date:7/30/2014)... As a leading outpatient surgery clinic ... boasts over 50 of the best physicians across fourteen ... Health Systems’ team are Dr. Benjamin Basseri and Dr. ... , Benjamin Basseri, MD, is a board-certified gastroenterologist. He ... followed by a fellowship in Gastroenterology at UCLA Medical ...
    Breaking Medicine News(10 mins):Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 2Health News:Victory Medical Center Craig Ranch Debuts Pediatric Care Unit 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3Health News:Blood Test Might Help Prevent Certain Birth Defects 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3Health News:La Peer Welcomes Two New Gastroenterologists 2Health News:La Peer Welcomes Two New Gastroenterologists 3
    ... (Nasdaq: SIAL ) is pleased to announce ... Corporate Controller effective April 13, 2009. Kanan (age 46) ... President-Strategy & Corporate Development. He will report to ... brings two decades of financial experience in assignments of ...
    ... Reovirus seeks out and destroys tumor cells, researchers say ... harmless human virus can target and kill breast cancer ... reovirus might be effective against cancer stem cells, because ... destroys regular cancer cells," Dr. Patrick Lee, a cancer ...
    ... Tau has been promoted to the position of Service ... at Baron Center, Inc (BCI). Dr. Tau is ... & forensic psychology. Dr. Tau is an expert in ... and has been extensively used as a workplace violence ...
    ... at Johns Hopkins have begun to tease out what there ... that leads so many patients to report depression after they ... 10 in Critical Care Medicine , the Hopkins researchers ... hospitalization among very sick ICU patients, including a high level ...
    ... dopamine agonists appear to curb compulsive acting out, study ... class of Parkinson,s disease drugs called dopamine agonists can ... gambling or hypersexuality, says a new study. , ... taking therapeutic doses of dopamine agonists, such as pramipexole ...
    ... Sinai faculty suggests that a gene associated with onset ... cases. The research, led by Dr. Giulio Maria Pasinetti, ... Professor of Psychiatry and Geriatrics and Adult Development at ... in the scientific journal, Archives of Neurology . ...
    Cached Medicine News:Health News:Sigma-Aldrich Announces Appointment of Michael Kanan as Vice President and Corporate Controller 2Health News:Harmless Virus May Be Deadly to Breast Cancer 2Health News:Manny Tau, Psy.D. Promoted to Service Area Leader for the Problematic Behaviors Service Area at Baron Center, Inc 2Health News:In the ICU, use of benzodiazepines, other factors may predict severity of post-stay depression 2Health News:Parkinson's Drugs Can Trigger Unhealthy Behaviors 2Health News:Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease 2
    Inquire...
    Sealing Mat for 384-well, Square Well Plates Available Sterile...
    96-well Silicone Expansion Mat, Bulk...
    Microseal 'M' mats, seals 96-well plates, reusable, pkg of 10...
    Medicine Products: